Utilising over sixty years of equity research experience, we provide listed & private companies and potential investors with insightful, bespoke, corporate research.
We aim to work with the client to provide a detailed, all-inclusive analysis of the business. This external opinion, which can be widely circulated (or retained privately for a bespoke project), provides investors with an authoritative view of the potential rewards, risks and key issues pertaining to any company in the life science or healthcare sector. Published in a familiar brokers’ research format, it communicates the key investment issues that cannot easily be addressed in a private company’s in-house business plan.
Our research provides essential credibility through third party endorsement and differentiation from other lower profile entities. This gives a significant edge in the fierce competition for investor attention. While this is a particularly valuable service for private companies seeking investor interest, it is also highly relevant for listed companies where lack of research and third party opinion (in Life Science companies technical insight is perhaps more valuable than in many other sectors) has allowed them to fall below the investor radar screen.